DRUG · Mapped RxNorm record
vorinostat
Normalized identity: vorinostatView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
NCT01174199
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
temsirolimus
Normalized identity: temsirolimusView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
positron emission tomography/computed tomography
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedTemsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
vorinostatDRUG · verified · RxNorm: vorinostat
temsirolimusDRUG · verified · RxNorm: temsirolimus
Sponsors & collaborators
Roswell Park Cancer Institutelead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01174199 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.